Diane Young, VP, Chief Medical Officer at Oncternal Therapeutics, holds 47.12K shares in Celldex (Ticker: CLDX), holds 45.94K shares in Oncternal Therapeutics (Ticker: ONCT).

See the Hottest Stocks Based on Insider Trading >

Diane Young
Oncternal Therapeutics (ONCT)
VP, Chief Medical Officer

Ranked #55,254 out of 98,564 Corporate Insiders

Profitable Transactions

2 out of 4 Profitable Transactions

Average Return

-3.50%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

81.55%

CLDX

18.45%

ONCT

A breakdown of Diane Young's holdings

See the Top Stocks by Insiders

Insider Roles

Celldex
(CLDX)

SVP, CHIEF MEDICAL OFFICER

Oncternal Therapeutics
(ONCT)

VP, Chief Medical Officer

Roles that Diane Young holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Celldex
(CLDX)

Rating:Informative Buy

Date:Jun 12, 2020 - Jun 12, 2021

Return:+297.90%

The most profitable trade made by Diane Young

See the Latest Stocks Traded by Insiders

Diane Young's Trading History

ONCT

Oncternal Therapeutics

Jul 17, 2018

VP, Chief Medical Officer

Uninformative Sell

30.05K

$402.63K

CLDX

Celldex

Aug 19, 2022

SVP, CHIEF MEDICAL OFFICER

Uninformative Sell

708.70K

$1.78M

List of latest transactions for each holding click on a transaction to see Diane Young's performance on stock

See All Insider Trading from Today

Diane Young insider profile FAQ

What is the percentage of profitable transactions made by Diane Young?

The percentage of profitable transactions made by Diane Young is 50%.

What is the average return per transaction made by Diane Young?

The average return per transaction made by Diane Young is -3.50%.

What stocks does Diane Young hold?

Diane Young holds: ONCT, CLDX stocks.

What was Diane Young’s latest transaction?

Diane Young latest transaction was an Uninformative Sell of $708.70K.

What was Diane Young's most profitable transaction?

Diane Young’s most profitable transaction was an Informative Buy of CLDX stock on June 12, 2020. The return on the trade was 297.90%.

What is Diane Young's role in Oncternal Therapeutics?

Diane Young's role in Oncternal Therapeutics is VP, Chief Medical Officer.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Diane Young Insider Profile

Diane Young Oncternal Therapeutics (ONCT)VP, Chief Medical Officer